Laxmisha Chandrashekar

Laxmisha Chandrashekar

Auto-generated profile, based on publicly available information

Laxmisha Chandrashekar

Department of Dermatology, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2016 in Annals of Allergy, Asthma & Immunology
Verified
Journal Article
Closed access
RVRosin Varghese
Rosin Varghese
MRMedha Rajappa
Medha Rajappa
LCLaxmisha Chandrashekar
Laxmisha Chandrashekar
SKShivanand Kattimani
Shivanand Kattimani
MAMony Archana
Mony Archana
DTDevinder Mohan Thappa
Devinder Mohan Thappa

4 January 2015 in British Journal of Biomedical Science
Verified
Journal Article
Closed access
LCL. Chandrashekar
L. Chandrashekar
GKG. R. Krishna Kumari
G. R. Krishna Kumari
MRM. Rajappa
M. Rajappa
GRG Revathy
G Revathy
MMM. Munisamy
M. Munisamy
DTD. M. Thappa
D. M. Thappa
Psoriasis is a T-helper-1 (TM)/TM7-mediated chronic inflammatory skin disease, characterised by hyperproliferation of keratinocytes. Psoriasis and cardiovascular disease share similar pathogenic mechanisms such as vascular endothelial cell dysfunction, oxidative stress and metabolic syndrome. 25-hydroxy vitamin D is an immune-regulatory hormone, with the ability to reduce cellular proliferation in psoriasis. Ischaemia-modified albumin (IMA) is a marker of oxidative stress. This study examined 25-hydroxy vitamin D, IMA and high-sensitivity C-reactive protein (hs-CRP) levels in patients with psoriasis, in comparison with healthy controls and their possible association with disease severity. A total of 43 cases of psoriasis and 43 controls were included in this cross-sectional study, and severity grading was performed according to psoriasis area severity index (PASI) scoring. Serum 25-hydroxy vitamin D, IMA and hs-CRP were evaluated in all study subjects. In psoriasis, 25-hydroxy vitamin D showed a significant decline, while hs-CRP and IMA levels were significantly elevated, as compared with controls. Serum 25-hydroxy vitamin D showed a significant negative correlation with PASI score. hs-CRP and IMA showed a significant positive correlation with PASI score. Significant negative correlation was observed between 25-hydroxy vitamin D and hs-CRP; 25-hydroxy vitamin D and IMA levels in psoriasis. The results indicate that psoriasis is associated with significantly lowered 25-hydroxy vitamin D levels, along with increased systemic inflammation and oxidative stress, especially in severe disease. Thus, vitamin D supplementation might reduce systemic inflammation and oxidative stress and help in delaying the pathogenesis of co-morbidities associated with psoriasis.

1 June 2015 in Clinica Chimica Acta
Verified
Journal Article
Closed access
LCLaxmisha Chandrashekar
Laxmisha Chandrashekar
MRMedha Rajappa
Medha Rajappa
GRG. Revathy
G. Revathy
ISIndhumathi Sundar
Indhumathi Sundar
MMMalathi Munisamy
Malathi Munisamy
DBDebdatta Basu
Debdatta Basu

1 January 2011 in Indian Journal of Dermatology, Venereology and Leprology
Verified
Journal Article
Open access
LCLaxmisha Chandrashekar
Laxmisha Chandrashekar

1 October 2015 in Asian Journal of Psychiatry
Verified
Journal Article
Closed access
DKDeepthi Konda
Deepthi Konda
LCLaxmisha Chandrashekar
Laxmisha Chandrashekar
MRMedha Rajappa
Medha Rajappa
SKShivanand Kattimani
Shivanand Kattimani
DTDevinder Mohan Thappa
Devinder Mohan Thappa
PAP.H. Ananthanarayanan
P.H. Ananthanarayanan

25 March 2014 in Journal of the European Academy of Dermatology and Venereology
Verified
Journal Article
Closed access
PDF file
MRM. Rajappa
M. Rajappa
SRS. Rathika
S. Rathika
MMM. Munisamy
M. Munisamy
LCL. Chandrashekar
L. Chandrashekar
DTD.M. Thappa
D.M. Thappa